Antibacterial and anti-PAF activity of lipid extracts from sea bass (Dicentrarchus labrax) and gilthead sea bream (Sparus aurata)

Food Chemistry

Volumn 111, Issue 2, 2008, Pages 433-438

  Nasopoulou, Constantina ^a   Karantonis, Haralabos C ^b   Andriotis, Michalis ^a   Demopoulos, Constantinos A ^a   Zabetakis, Ioannis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Antibacterial activity; Platelet activating factor (PAF); Sea bass; Sea bream

Indexed keywords

ANTIINFECTIVE AGENT; LIPID; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR AFFECTING AGENT;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; EUROPEAN SEA BASS; NONHUMAN; SEA BREAM; STAPHYLOCOCCUS AUREUS; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

ARCHOSARGUS RHOMBOIDALIS; DICENTRARCHUS LABRAX; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; SERRANIDAE; SPARUS AURATA; STAPHYLOCOCCUS AUREUS;

EID: 51749125863     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2008.04.011     Document Type: Article

References (41)

1. Andriotis, M., Demopoulos, C. A., Tournis, S., Siafaka, A., & Mavris, M. (1986). Evidence for the existence of PAF bacteria. In Platelet-activating factor. The second international conference. Tennessee, USA.
2. Archer C.B. Platelet activating factor - A mediator of inflammation in the skin-medical implications. Clinical and Experimental Dermatology 6 18 (1993) 489-495
3. Bermejo V.E., Gonzalez M.E., Martinez A.M., Zubia A.A., Nieves G.A., Salado M.C., et al. Pneumatocele as a complication of E. coli pneumonia in a newborn infant. Apropos of a cas. Anales Espnoles de Pediatria 6 37 (1992) 526-528
4. Bishop E.J., and Howden B.P. Treatment of Staphylococcus aureus infections: New issues, emerging therapies and future directions. Expert Opinion on Emerging Drugs 1 12 (2007) 1-22
5. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 8 37 (1959) 911-917
6. Chambers H.F. The changing epidemiology of Staphylococcus aureus. Emerging Infectious Disease 2 7 (2001) 178-182
7. Czaban S.L., Lebkowski W.J., Krajewski J.P., and Borkowski J. The efficacy of intraventricularly administered vancomycin in the case of central nervous system infection caused by Enterococcus faecalis. Wiadomosci Lekarskie 9-10 55 (2002) 617-625
8. DeJoy S.Q., Jeyaseelan Sr. R., Torley L.W., Pickett W.C., Wissner A., Wick M.M., et al. Effect of CL 184,005, a platelet-activating factor antagonist in a murine model of Staphylococcus aureus-induced gram-positive sepsis. The Journal of Infectious Disease 1 169 (1994) 150-156
9. Demopoulos C.A., Pinckard R.N., and Hanahan D.J. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). The Journal of Biological Chemistry 19 254 (1979) 9355-9358
10. Denizot Y. Endogenous or exogenous origin of platelet-activating factor in cerebrospinal fluid of children with bacterial meningitis. The Journal of Infectious Disease 5 163 (1991) 1164
11. Denizot Y., Dassa E., Benveniste J., and Thomas Y. Paf-acether production by Escherichia coli. Biochemical and Biophysical Research Communication 2 161 (1989) 939-943
12. Faraj A.A. Streptococcus faecalis disc space infection following transurethral resection of prostate. European Spine Journal 3 5 (1996) 204-206
13. Feuerstein G.Z. Platelet-activating factor: A case for its role in CNS function and brain injury. Journal of Lipid Mediators and Cell Signalling 1-3 14 (1996) 109-114
14. Galanos D.S., and Kapoulas V.M. Isolation of polar lipids from triglyceride mixtures. Journal of Lipid Research 1-3 1 (1962) 134-137
15. Heuer H.O., Darius H., Lohmann H.F., Meyer J., Schierenberg M., and Treese N. Platelet-activating factor type activity in plasma from patients with septicemia and other diseases. Lipids 12 26 (1991) 1381-1385
16. Ikeda I., Oda M., Sakakura M., and Yasunaga K. Presence of platelet-activating factor in pyuria in humans. Lipids 12 26 (1991) 1333-1335
17. Johnson J.R., Kuskowski M.A., Menard M., Gajewski A., Xercavins M., and Garau J. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. The Journal of Infectious Disease 1 194 (2006) 71-78
18. Kayser F.H., Bienz K.A., Eckert J., and Zinkernagel R.M. Bacteriology. Medical microbiology (2005), Thieme, New York 146-345
19. Kusuda M., Inada K., Ogawa T.O., Yoshida T., Shiota S., Tsuchiya T., et al. Polyphenolic constituent structures of Zanthoxylum piperitum fruit and the antibacterial effects of its polymeric procyanidin on methicillin-resistant Staphylococcus aureus. Bioscience, Biotechnology and Biochemistry 6 70 (2006) 1423-1431
20. Maruzumi M., Morita M., Matsuoka Y., Uekawa A., Nakamura T., and Fuji K. Mass food poisoning caused by beef offal contaminated by Escherichia coli O157. Japanese Journal of Infectious Diseases 6 58 (2005) 397
21. Miorin P.L., Levy Junior N.C., Custodio A.R., Bretz W.A., and Marcucci M.C. Antibacterial activity of honey and propolis from Apis mellifera and Tetragonisca angustula against Staphylococcus aureus. Journal of Applied Microbiology 5 95 (2003) 913-920
22. Montrucchio G., Mariano F., Cavalli P.L., Tetta C., Viglino G., Emanuelli G., et al. Platelet activating factor is produced during infectious peritonitis in CAPD patients. Kidney International 6 36 (1989) 1029-1036
23. Nasopoulou C., Nomikos T., Demopoulos C.A., and Zabetakis I. A Comparison of antiatherogenic properties of lipids obtained from wild and cultured Sea Bass (Dicentrarchus labrax) and Gilthead Sea Bream (Sparus aurata). Food Chemistry 2 100 (2007) 560-567
24. Nomikos T., Karantonis H.C., Skarvelis C., Demopoulos C.A., and Zabetakis I. Antiatherogenic properties of lipid fractions of raw and fried fish. Food Chemistry 96 (2006) 29
25. Ogata M., Nandate K., Kawasaki T., Kawasaki C., Ozaki M., and Shigematsu A. A platelet activating factor receptor antagonist inhibits cytokine production in human whole blood by bacterial toxins and live bacteria. Anesthesia and Analgesia 6 98 (2004) 1767-1772
26. Ono S., Muratani T., and Matsumoto T. Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 7 49 (2005) 2954-2958
27. Panayiotou A., Samartzis D., Nomikos T., Fragopoulou E., Karantonis H.C., Demopoulos C.A., et al. Lipid fractions with aggregatory and antiaggregetory activity toward platelets in fresh and fried cod (Gadus morhua): Correlation with platelet-activating factor and atherogenesis. Journal of Agriculture and Food Chemistry 48 (2000) 6372
28. Pedersen M., Benfield T.L., Skinhoej P., and Jensen A.G. Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases. BMC Infectious Diseases 6 (2006) 49
29. Pinckard R.N., Farr R.S., and Hanahan D.J. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. Journal of Immunology 123 (1979) 1847
30. Prasad R., Mishra O.P., and Pant P. Deep vein thrombosis with Staphylococcus aureus septicemia. Indian Pediatrics 1 44 (2007) 43-45
31. Rementzis J., Antonopoulou S., Argyropoulos D., and Demopoulos C.A. Biologically active lipids from Scomber scombrus. Experimental Medical Biology 416 (1996) 65
32. Ruddock P.S., Liao M., Foster B.C., Lawson L., Arnason J.T., and Dillon J.A. Garlic natural health products exhibit variable constituent levels and antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis. Phytotherapy Research 4 19 (2005) 327-334
33. Ryan K.J. Sherris medical microbiology: An introduction to infectious diseases (2004), McGraw-Hill, New York
34. Schwarz M.D., and Rosen R.A. Neonatal mastitis due to E. coli. Clinical Pediatrics (Phila) 1 13 (1974) 86
35. Shiono A., and Ike Y. Isolation of Enterococcus faecalis clinical isolates that efficiently adhere to human bladder carcinoma T24 cells and inhibition of adhesion by fibronectin and trypsin treatment. Infection and Immunity 4 67 (1999) 1585-1592
36. Suttorp N., Buerke M., and Tannert-Otto S. Stimulation of PAF-synthesis in pulmonary artery endothelial cells by Staphylococcus aureus alpha-toxin. Thrombosis Research 2 67 (1992) 243-252
37. Szymborski J., and Komar M. Clinical analysis of 18 cases of E. coli septicemia in children. Wiadomosci Lekarskie 22 42 (1989) 1115-1118
38. Toda M., Okubo S., Hara Y., and Shimamura T. Antibacterial and bactericidal activities of tea extracts and catechins against methicillin resistant Staphylococcus aureus. Nippon Saikingaku Zasshi 5 46 (1991) 839-845
39. Tsigrelis C., Singh K.V., Coutinho T.D., Murray B.E., and Baddour L.M. Vancomycin-resistant Enterococcus faecalis endocarditis: Linezolid failure and strain characterization of virulence factors. Journal of Clinical Microbiology 2 45 (2007) 631-635
40. van der Sluijs K.F., van Elden L.J., Nijhuis M., Schuurman R., Florquin S., Shimizu T., et al. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. American Journal of Physiology, Lung Cellular and Molecular Physiology 1 290 (2006) L194-L199
41. Xu H., Iijima K., Shirakawa T., Shiozawa S., Miwa M., Yamaoka K., et al. Platelet-activating factor acetylhydrolase gene mutation in Japanese children with Escherichia coli O157-associated hemolytic uremic syndrome. American Journal of Kidney Disease 1 36 (2000) 42-46